Biote (BTMD) Non-Current Deffered Revenue (2020 - 2026)

Biote has reported Non-Current Deffered Revenue for 7 years, with the latest figure at $922000.0 in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Deffered Revenue fell 36.41% year-over-year to $922000.0; the trailing twelve-month figure through Mar 2026 stood at $922000.0 (down 36.41% YoY), and the FY2025 full-year result was $1.1 million, down 29.36% from the prior year.
• Non-Current Deffered Revenue for Q1 2026 stood at $922000.0, down from $1.1 million in the prior quarter.
• The five-year high for Non-Current Deffered Revenue was $11.1 million in Q1 2022, with the low at $853000.0 in Q2 2022.
• Average Non-Current Deffered Revenue over 5 years is $1.8 million, with a median of $1.2 million recorded in 2025.
• Year-over-year, Non-Current Deffered Revenue slumped 92.32% in 2022 and soared 44.16% in 2024.
• Tracing BTMD's Non-Current Deffered Revenue over 5 years: stood at $926000.0 in 2022, then jumped by 42.76% to $1.3 million in 2023, then rose by 17.47% to $1.6 million in 2024, then declined by 29.36% to $1.1 million in 2025, then declined by 15.95% to $922000.0 in 2026.
• The last three Non-Current Deffered Revenue figures came in at $922000.0 (Q1 2026), $1.1 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.

Peer Comparison